The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may ...

In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...

Phenylephrine is a medication that’s been used to relieve nasal congestion caused by colds, allergies, and hay fever, per the ...

said during the advisory committee meeting in September. "Design a real study, do a real study, then we can talk about the ...

The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal ...

FDA officials said an agency review of the available data found oral phenylephrine is not effective as a nasal decongestant ...

The FDA announced on Thursday a proposed order to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) ...

While an FDA advisory committee saw signals of efficacy for Lexicon Pharmaceuticals’ sotagliflozin, the panel of external ...

Committee members said there was uncertainty around sotagliflozin in patients with kidney disease. The FDA is currently ...